Pore formation, polymerization, hemolytic and leukotoxic effects of a new Enterobacter cloacae toxin neutralized by antiserum.
A new toxin of Enterobacter cloacae was purified and studied by SDS-PAGE electrophoresis with the purpose of investigating its ability to generate polymers and their molecular mass. Monomer of 13.3 kDa and structures of multimeric mass were detected. The toxin of 66 kDa was the most abundant form of toxin. This polymer and the monomer were selected to examine blood cells damage. Membrane pores caused by both toxin forms seemed to be of similar dimension (estimated in 3.6 nm by experiments with osmotic protectors) and were able to lyse erythrocytes and leukocytes. The results obtained indicate that polymerization and pore formation are involved in the molecular events that participate in the cytotoxic effects of E. cloacae toxin. Immunization of rabbits with 13.3kDa toxin generated antibody response capable of inhibiting oxidative stress as well as hemolytic and leukotoxic effects. Immunoblotting indicated that monomer and polymer reacted with antihemolysin serum. The importance of E. cloacae toxin "in vivo" was studied in animals by means of assays performed in peritoneum of rats, inoculated with the hemolytic strain (C1) and a non-hemolytic variant (C4). Both strains stimulated infiltration of leukocytes in peritoneum, but C1 caused cell death and lysis wheras assays with C4 maintained the viability of leukocytes even within 5 h after extraction of samples.
Paraje
María Gabriela
MG
Departamento de Farmacia, Facultad de Ciencias Quimicas, Universidad Nacional de Córdoba, Ciudad Universitaria, 5000 Córdoba, Argentina. paraje@dqo.fcq.unc.edu.ar
Eraso
Alberto Jorge
AJ
Albesa
Inés
I
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D001427:Bacterial Toxins / Q000008:administration & dosage / Q000737:chemistry / Q000302:isolation & purification / Q000633:toxicity; D016972:Enterobacter cloacae / Q000378:metabolism* / Q000472:pathogenicity*; D004756:Enterobacteriaceae Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control; D004910:Erythrocyte Membrane / Q000187:drug effects; D004912:Erythrocytes / Q000187:drug effects; D006461:Hemolysis; D007114:Immunization; D007962:Leukocytes / Q000473:pathology; D009500:Neutralization Tests; D018384:Oxidative Stress / Q000276:immunology; D011108:Polymers / Q000378:metabolism*; D011817:Rabbits; D051381:Rats
D000907:Antibodies, Bacterial; D001427:Bacterial Toxins; D011108:Polymers